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Abstract
Background: Many community-based self-management programs have been developed for older adults with type-
2 diabetes mellitus (T2DM), bolstered by evidence from randomized controlled trials (RCTs) that T2DM can be
prevented and managed through lifestyle modifications. However, the evidence for their effectiveness is
contradictory and weakened by reliance on single-group designs and/or small samples. Additionally, older adults
with multiple chronic conditions (MCC) are often excluded because of recruiting and retention challenges. This
paper presents a protocol for a two-armed, multisite, pragmatic, mixed-methods RCT examining the effectiveness
and implementation of the Aging, Community and Health Research Unit-Community Partnership Program (ACHRU-
CPP), a new 6-month interprofessional, nurse-led program to promote self-management in older adults (aged 65
years or older) with T2DM and MCC and support their caregivers (including family and friends).
Methods/design: The study will enroll 160 participants in two Canadian provinces, Ontario and Alberta. Participants
will be randomly assigned to the control (usual care) or program study arm. The program will be delivered by
registered nurses (RNs) and registered dietitians (RDs) from participating diabetes education centers (Ontario) or
primary care networks (Alberta) and program coordinators from partnering community-based organizations. The 6-
month program includes three in-home visits, monthly group sessions, monthly team meetings for providers, and
nurse-led care coordination. The primary outcome is the change in physical functioning as measured by the
Physical Component Summary (PCS-12) score from the short form-12v2 health survey (SF-12). Secondary client
outcomes include changes in mental functioning, depressive symptoms, anxiety, and self-efficacy. Caregiver
outcomes include health-related quality of life and depressive symptoms. The study includes a comparison of
health care service costs for the intervention and control groups, and a subgroup analysis to determine which
clients benefit the most from the program. Descriptive and qualitative data will be collected to examine
implementation of the program and effects on interprofessional/team collaboration.
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Discussion: This study will provide evidence of the effectiveness of a community-based self-management program
for a complex target population. By studying both implementation and effectiveness, we hope to improve the
uptake of the program within the existing community-based structures, and reduce the research-to-practice gap.
Trial registration: ClinicalTrials.gov, Identifier: NCT02158741. Registered on 3 June 2014.
Keywords: Type-2 diabetes mellitus, Randomized controlled trial, Pragmatic, Hybrid effectiveness-implementation
design, Self-management, Group-based programs, Community-based settings, Health-related quality of life, Older
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Background
The prevalence of diabetes is increasing in countries
across the globe, particularly type-2 diabetes mellitus
(T2DM) [1]. Currently, 347 million people have diabetes
worldwide and this is expected to increase by 55% by
2035 [1, 2]. T2DM comprises 90% of all diabetes cases
[3] and results from genetic, behavioral, and environ-
mental risk factors [1, 4]. Advancing age is associated
with T2DM, with older adults having the highest preva-
lence of T2DM of any age group [1, 5]. Among older
adults, T2DM frequently occurs in conjunction with
other comorbidities [1, 6, 7]. Studies suggest that up-
wards of 40% or more people with T2DM have three or
more comorbid health conditions [8–10]. When consid-
ered within the context of other comorbidities, T2DM
represents a significant burden in older adults that is
linked to higher mortality, reduced functional status, in-
creased use of health care services, and higher risk of
institutionalization [5, 11]. Thus, there is an urgent re-
quirement to provide services that meet the needs of this
complex population.
There is strong evidence that the primary determi-
nants of T2DM, notably smoking, poor diet, obesity,
and physical inactivity are modifiable through self-
management activities [2, 12–17]. From large clinical
trials, such as the American Diabetes Prevention Pro-
gram (DPP) [18] and the Finnish Diabetes Prevention
Study (FDPS) [19, 20], there is evidence that lifestyle
and weight-loss programs can reduce the incidence of
diabetes by up to 58%. The benefits can be enduring
[4]; one study reported a 34% reduction in incidence
rates among its intervention group during a 10-year
follow-up [21] and a 4-year study reported sustained
weight loss and improved cardiovascular risk factors
following intensive lifestyle intervention [22]. Thus,
aggressive public policy initiatives have been recom-
mended to encourage self-management of lifestyle
change [23]. Strong support for these initiatives can
be found in a recent systematic review showing that
integrated care interventions for people with T2DM
(which target self-management and patient-centered,
team-based approaches to care) can result in im-
provements in a range of clinical and patient-reported
outcomes, with no studies reporting a worsening in
outcomes [24].
Clinic-based lifestyle interventions like the DPP and
FDPS require substantial resources (e.g., specialized ex-
pertise, individual settings); thus, researchers have
assessed whether interventions delivered in community
settings might be an effective, economical, and feasible
alternative. Recent international studies, for example,
have reported that group-based diabetes programs,
established in community settings, result in improved
clinical, lifestyle, and psychosocial outcomes compared
to routine care [25–27]. Importantly, community-based
programs have proven to be scalable and sustainable at a
national level [28] and they are beneficial to individuals
of many ages, including older adults [29–31]. In a sys-
tematic review involving 16 studies that translated the
DPP into hospital, primary care, community, and work
settings Whittemore [32] concluded that programs
linked to existing structures of care, (e.g., the Young
Men’s Christian Association, or YMCA) may enhance
adoption, implementation, and maintenance of the
program.
While there is strong evidence for self-management
interventions in general, the existing research, particu-
larly for community-based interventions, has limitations.
Notably, evidence for their effectiveness is equivocal.
Whittemore [32] concluded that self-management inter-
ventions delivered in community settings, despite their
ability to reach diverse populations, reported less weight
loss than those interventions offered in more restricted
settings, such as hospitals. In contrast, studies by Ali
et al. [33] and Ruggiero et al. [34] found that interven-
tions with community components (e.g., lay members or
community health workers) resulted in more weight loss
compared to those run by medical or allied health pro-
fessionals. A different challenge relates to validity and
reliability since many effectiveness studies of
community-based interventions rely on single-group de-
signs and/or pilot studies with small samples [35]. Add-
itionally, comparatively few studies have examined the
effectiveness of lifestyle interventions in older adults
with T2DM and comorbid conditions, because this
population is typically excluded from randomized
Markle-Reid et al. Trials  (2017) 18:55 Page 2 of 16
controlled trials (RCTs) [5, 36]. With their increased risk
of comorbidity and geriatric syndromes, such as cogni-
tive impairment, falls, and depression [37–40], this med-
ically complex population is typically more difficult to
reach, recruit, and retain [7]. Thus, there is uncertainty
about the clinical effectiveness of self-management inter-
ventions for older adults with multiple chronic condi-
tions (MCC). More information is also needed on
adapting community-based interventions to individual
settings, the effectiveness of interventions in key patient
subgroups, and operational costs.
The purpose of this article is to describe a study de-
signed to examine the effectiveness and implementation
of the Aging, Community and Health Research Unit-
Community Partnership Program (ACHRU-CPP), a new
6-month interprofessional, nurse-led program to pro-
mote self-management in older adults (aged 65 years
and older) with T2DM and MCC and their family care-
givers (including family and friends). The description
follows the Standard Protocol Items: Recommendations
for Interventional Trials (SPIRIT) guidelines [41], which
provide a list of the recommended items to include in
clinical trial protocols. The populated SPIRIT Checklist
is available in Additional file 1. The trial is a multisite,
two-arm, pragmatic, mixed-methods RCT that employs
a type-2 hybrid design which simultaneously evaluates
both clinical effectiveness (e.g., Does the intervention
work?) and implementation (e.g., Is the intervention de-
livery feasible and acceptable?) [41]. The participant
timeline recommended by SPIRIT [41] shows the sched-
ule of enrollment, interventions, and assessments (see
Fig. 1) and these are all discussed in greater detail below.
Hybrid designs are thought to facilitate the transition
from research to practice and result in more rapid up-
take of effective interventions [42]. The trial is based on
a pilot study, where the program’s feasibility and poten-
tial effectiveness were demonstrated [43].
Objectives
The aim of the trial is to evaluate the clinical effective-
ness and implementation of the ACHRU-CPP, compared
to usual care. We hypothesize that clients in the inter-
vention group will experience greater improvements in
health-related quality of life (HRQoL) compared to the
usual care group. We also expect that the program will
improve outcomes for family caregivers, improve inter-
professional team functioning among the intervention-
ists, and be feasible to implement in practice at no
Fig. 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Checklist: schedule of enrollment, interventions,
and assessments
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additional cost. The study will address the following spe-
cific objectives:
1. To compare the effects of the intervention versus
usual care on older adults’ HRQoL, diabetes self-
management, self-efficacy, depressive symptoms,
anxiety, and the costs of use of health services (from
a societal perspective)
2. To determine the subgroups of older adults that
benefit most from the program
3. To compare the effects of the intervention versus
usual care on family caregivers’ HRQoL, strain,
depressive symptoms, and the costs of use of health
services (from a societal perspective), and
4. To evaluate the implementation of the program and
its effects on interprofessional/team collaboration
Methods/design
This study is a pragmatic RCT which combines a quan-
titative analysis of the effects of the intervention with a
qualitative and quantitative analysis of the implementa-
tion and contextual factors potentially associated with
variations in the outcomes in the real world. Combining
quantitative and qualitative analyses in an intervention
study has been referred to as a concurrent, embedded
mixed-methods design in the mixed-methods literature
[44] and a hybrid trial in the interventions literature
[42]. The choice to include both quantitative and quali-
tative methods in our study reflects our view that no
single method can fully answer the questions posed by
an intervention study. While an RCT is regarded as the
“gold standard” for establishing effectiveness of interven-
tions, effect sizes do not provide policy-makers with in-
formation on how an intervention might be replicated in
their specific context, or whether trial outcomes can be
reproduced. Guidelines for evaluating complex interven-
tions have been updated to recognize the value of using
qualitative research methods to complement the quanti-
tative effects [45].
Figure 2 provides the overall evaluation framework for
the trial. The evaluation of effectiveness and implemen-
tation outcomes, while discussed separately below, will
occur simultaneously, receive equal emphasis, and are
recognized as often dependent on each other (e.g., the
effectiveness of the intervention will depend on the qual-
ity and success of the implementation strategy and
process). Our approach of assigning equal weight to the
effectiveness and implementation components of the
study is consistent with a type-2 hybrid trial [42]. Imple-
mentation outcomes examined in the trial are guided by
two published frameworks: the broad implementation
research framework by Peters et al. [46] and the Consoli-
dated Framework for Implementation Research (CFIR)
for systematically identifying contextual factors that can
impact intervention implementation, adoption and
maintenance by Damschroder et al. [47]. The Peters
et al. [46] framework recognizes a range of implementa-
tion outcomes including: acceptability, adoption, appro-
priateness, feasibility, fidelity, cost, coverage, and
sustainability. The CFIR provides a focused set of con-
structs to evaluate barriers and facilitators including
characteristics of the intervention, outer and inner set-
ting, individuals delivering the intervention, and the im-
plementation process. We have developed research
questions and quantitative measures and/or qualitative
inquiries corresponding to each implementation out-
come from these two frameworks.
Participants and setting
A strategic first step for this study was the development of
a partnership between researchers in the Aging, Commu-
nity and Health Research Unit (ACHRU) at McMaster
University (Hamilton, ON, Canada) and the University of
Alberta (Edmonton, AB, Canada), program coordinators
from seven community-based organizations, and seven
Fig. 2 Type-2 hybrid effectiveness – Implementation evaluation framework
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diabetes education centers (Ontario) or primary care net-
works (Alberta). The study will enroll 160 participants in
each of two Canadian provinces, Ontario and Alberta. Al-
though these provinces are in the same country, they en-
compass diverse characteristics in terms of geography
(Ontario is in the east, Alberta the west), culture, and health
care system structure. In Ontario, study participants will be
recruited from clients who have been recently referred for
diabetes-related services to diabetes education centers
(DECs). DECs are regional centers that provide ongoing
diabetes education programs, counselling and follow-up
sessions by registered nurses (RNs) and registered dietitians
(RDs) for clients and their families. In Alberta, study partic-
ipants will be recruited from clients who have been recently
referred to diabetes or chronic disease management pro-
grams at three primary care networks (PCNs). PCNs are
centralized resource facilities that provide equipment and
health care teams to service clients from physician clinics
in close proximity to one another. The Ontario and Alberta
provinces were selected to compare and contrast different
health care systems. The specific sites within each province
were selected because they serve a large and growing older
adult population, and demonstrated strong support for the
program. Community partner organizations were selected
and invited based on existing collaborations with the sites
and/or interest in health promotion for community-
dwelling older adults. The community partners were also
selected based on availability and accessibility of an appro-
priate space to host monthly group program sessions and
availability of staff members to participate in program deliv-
ery (e.g., a program coordinator for the group sessions).
In order to participate in the study, clients must satisfy
the following inclusion criteria:
 have enrolled in a DEC (Ontario) or referred to a
PCN (Alberta) within the past 24 months, or
recruited from the community
 65 years of age or older
 diagnosed with at least two chronic conditions in
addition to T2DM
 not planning to move away from the community in
the next 6 months, and
 able to speak English (or with an interpreter available)
These inclusion criteria were designed to be minimally
stringent in order to facilitate the broad applicability of
the results to the general population of community-
dwelling older adults with T2DM and MCC. Aspects of
specific criteria were also selected to ensure consistency
with broader research initiatives.
Screening for eligibility and enrolment
In Ontario, trained DEC staff will identify potential cli-
ents based on the inclusion criteria and then contact
them by phone to obtain verbal consent to be contacted
by a research assistant (RA). A RA will then conduct an
in-home interview to obtain written informed consent
and complete the baseline questionnaires. Differing le-
gislation required that study personnel use a different
approach in Alberta. First, the recruiter identifies poten-
tial clients and then establishes their eligibility and inter-
est. If written consent-to-be-contacted was obtained
during recruitment, the client would be contacted by a
RA. If there was no written consent-to-be-contacted,
then it would be left to the potential client to contact
the research team. At the time of recruitment, all eligible
clients will be asked to invite their family caregivers
(family or friend of at least 18 years of age who provides
physical, emotional, or financial care to the client) to
participate in the study, and provide their contact infor-
mation. Participation of a family caregiver is encouraged
but not required.
At the initial home visit the RA will first administer
the Short Portable Mental Status Questionnaire [48] to
assess the client’s mental status. A score of 5 or higher is
required for the client to provide consent, and if the cli-
ent scores below 5, their family caregiver will be invited
to consent on behalf of the client. Once the appropriate
informed consent has been received, study clients and/
or their family caregivers will complete the baseline
interview and questionnaires. Interviews and completion
of the questionnaires is expected to take about 2 h.
Program
The RCT is pragmatic, which means that the program
will be implemented under real-world conditions, in-
cluding reliance on existing staff at participating sites. A
detailed description of the program is available else-
where [43]. The program will be delivered by an inter-
professional team consisting of RDs and RNs from the
participating DECs/PCNs and a program coordinator
(PC) from the community partner agencies. As the pro-
gram is designed to work with the existing personnel
within these organizations, there may be additional pro-
fessionals, such as kinesiologists or pharmacists, who are
part of the interprofessional teams. The providers in-
volved in delivering the program in each study site will
not provide care to participants randomized to the usual
care group. Clients randomly assigned to the control
group will continue to be offered usual care services
through their local DEC/PCN. The specific services that
comprise usual diabetes care vary across both provinces
in terms of the length and focus of educational sessions,
whether classes are strongly recommended versus op-
tional (e.g., foot care, cardiac health, eating and exercise
interventions), access to on-site professionals (e.g., endo-
crinologist, dietician, physiotherapist, exercise specialist,
pharmacist), connections with support services and
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community resources, and type of follow-up services
available.
Clients randomly assigned to the intervention group
will be offered the program in addition to the usual care
services that they currently receive. The program is a 6-
month, multicomponent, client-driven strategy that was
designed to support self-management of diabetes and
other MCC. It was tested in a pilot study, and was modi-
fied based on the feedback received from clients and in-
terventionists [43]. The program consists of the
following components: (1) up to three in-home visits by
an RN and RD, (2) a monthly group wellness program,
hosted by the community partner agency and supported
by peer volunteers, (3) monthly case conferences involv-
ing the RN, RD, PC, and (3) care coordination and navi-
gation to link clients to other health care professionals
and community support services as needed. Because the
program is client-driven, there is flexibility in the com-
ponents in terms of the mode of delivery, specific activ-
ities emphasized, and dosage. For example, the client
may decline one or more home visits or group sessions,
or they may choose the DEC/PCN or alternate setting
instead of their home for the visits. A graphical display
outlining the intervention versus usual care services is
available in Additional file 2 [49].
The fundamental principles underlying the compo-
nents of the client-driven program are self-efficacy, col-
laboration, holistic care, and caregiver engagement and
support (Table 1). The client is a key member of the care
team and is fully engaged in the development of a care
plan that is tailored to their individual needs and prefer-
ences. The central role of the client is consistent with
the current policy priorities of the Ontario [50] and Al-
berta [51] health ministries. Client self-efficacy, a major
determinant of a person’s behavior and motivation to
take action, has been found to be a predictor of diabetes
self-management [52]. Bandura, the psychologist
credited with first recognizing the central role of self-
efficacy in behaviour, defined self-efficacy as “the belief
in one’s capabilities to organize and execute the courses
of action required to manage prospective situations”
([53], p. 2). Key sources of self-efficacy are mastery, so-
cial modelling, social persuasion and psychological state
such as mood and stress [54]. Various aspects of the
program target these sources, including: home visits and
group sessions which include education and
reinforcement of appropriate self-management principles
and activities; group sessions which provide opportun-
ities for social modelling and persuasion; home visits
which include motivational interviewing to encourage
positive psychological states and celebrate successes by
modifying goals and care plans as participants master
self-management tasks; and meaningful and inclusive
collaboration involving all members of the care team, in-
cluding clients and their caregivers, to foster their com-
mitment and deeper interest in diabetes self-
management.
Program implementation strategy
A four-pronged approach will be used by the researchers
to implement and monitor the delivery of the program
at each site to ensure trial adherence:
 Educational workshops: the investigators will hold
training sessions for the interventionists and peer
support volunteers before implementation of the
program. Each session will be supported with role-
appropriate training manuals
 Outreach visits: the investigators and research
coordinators will conduct monthly meetings either
in person or by teleconference with the
interventionists and peer support volunteers with
each of the seven sites to discuss the progress of the
study, provide feedback and education, and discuss
Table 1 Principles underpinning the Aging, Community and Health-Community Partnership Program (ACHRU-CPP)
Component Feature(s)
Self-efficacy • strengthening confidence of clients and their family caregivers in their abilities to monitor their health, make
decisions, and adopt healthy self-care behaviors
Collaborative practice • involving all members of the care team (interventionists, clients and family caregivers) in all decisions relating to the
program
• emphasizing flexibility in responses so that individual client preferences can be effectively met
• integrating and sharing knowledge from all members of the care team into decisions
• optimizing the scopes of practice of the interventionists (e.g., professionals trained in health promotion and
prevention can fully utilize these skills, all team members can participate in care planning)
Holistic care • working with clients to apply self-management principles to the unique set of chronic conditions and risk factors they
face (e.g., income, social supports)
• developing a care plan that is realistic in view of the client’s strengths, challenges and preferences
• integrating evidence-based practices for diabetes with those relating to the other chronic conditions
Caregiver engagement and
support
• inviting caregivers to actively participate in home visits, group sessions, and case conferences
• incorporating caregiver insights/feedback into the development of a care plan that best meets the client’s needs
• ensuring that support services are provided to caregivers to promote their health and wellbeing and assist them in
the caregiving role
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barriers encountered and possible solutions for
identified barriers
 Reminders: the investigators and research
coordinators will provide updates on the study to
the interventionists and managers of the
participating DECs/PCNs and community partner
agencies, including successes and areas for
improvement related to the program
 Audit and feedback: the interventionists will be
asked to complete forms (i.e., visit reports and team
meeting records) related to program-specific activ-
ities that were carried out. At 1-month intervals, the
investigators and research coordinators will conduct
audits of the study-related documentation to assess
fidelity to the program (refer to Additional file 3)
Participant flow, assessments and timeline
The study involves two assessments: one at baseline (T1)
and the other 6 months after baseline (T2). At baseline,
data will be collected on demographic, clinical, and so-
cioeconomic variables in addition to assessment of the
primary and secondary outcome variables. The flow of
participants through the study phases will be presented
using a flow diagram which conforms to the Consoli-
dated Standards of Reporting Trials (CONSORT) guide-
lines [55] for pragmatic trial reporting (Fig. 3).
Fig. 3 Flow diagram of progress through study phases
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Sample size
The sample size for the RCT was calculated to detect a
minimally important difference (MID) in the primary
outcome measure (PCS-12). The developers suggest that
the MID for interpretation of group mean PCS-12 score
differences is approximately 3.0, which corresponds to
an effect size of 0.30 [56]. However, the developers also
acknowledge that this MID estimate is a matter of on-
going debate. Robust research on effect sizes seen across
a range of studies using a variety of quality-of-life mea-
sures has shown that the mean effect size is remarkably
consistent at 0.50, or half the standard deviation [57].
This effect size is close to the one observed in our pilot
study, which was 0.40 [43].
We based our estimate of the sample size on an effect
size of 0.50, 5% alpha, 80% power and 20% attrition
(18% was observed in our pilot study). Using these as-
sumptions, the sample size was 80 (each) for the inter-
vention and control groups.
Randomization design
After providing written, informed consent and complet-
ing the baseline questionnaires, participants will be
randomly assigned to either the intervention or the
control arm of the study using a 1:1 allocation ratio.
Stratified permuted block randomization will be used
to assign participants to the control and intervention
groups. Study sites are expected to be relatively
homogeneous regarding client sociodemographic and
clinical characteristics and the delivery of intervention
and usual care services. However, to minimize the
confounding effects of possible differences among the
study sites, the sites will be used as a stratum. The
randomized sequence at each site will be based on as-
signments of blocks randomly selected from sizes of
2, 4, or 6. A biostatistician not involved in the re-
cruitment process will generate the random number
assignments for each site using SAS Version 9.3. Ran-
dom number sequences will be input into a central-
ized web-based randomization service (REDCap) that
will allocate clients to the control or intervention
group at each site in accordance with the sequence.
Blinding
After randomization, the interventionists and clients will
know the group assignments. This lack of blinding is un-
avoidable; however, efforts will be made to blind the as-
sessors who conduct the 6-month assessment. Some
unblinding may occur, for example, if a client describes a
home visit or group session in their interview with the
assessor, even if such information is not requested. The
statistician/data analyst will be blinded to the group
assignments.
Analysis of clinical effectiveness
Outcome measures Table 2 describes the primary and
secondary outcome measures used to evaluate clinical
Table 2 Effectiveness outcomes, target population, and analysis
Effectiveness outcomes
Variable/outcome Hypothesis Measure Group(s)a Method of analysis




CT, CG Means and standard deviations,
t tests for comparing change from
baseline (T1) to 6 months (T2) in
the intervention and control groups
ANCOVA analysis to explore predictors
of primary outcome
multiple regression with backward
selection
to explore impact of dose on
primary outcome
Mental functioning Improve more in the
intervention group
Mental Component Summary




Larger reduction in the
intervention group
Center for Epidemiological Studies
Depression Scale (CES-D-10) [62–65]
CT, CG
Anxiety Larger reduction in the
intervention group
Generalized Anxiety Disorder
7-item Scale (GAD-7) [66–70]
CT
Self-management More improvement in the
intervention group
Summary of Diabetes Self
Care Activities (SDSCA) [71, 72]
CT






Caregiver strain Larger reduction in the
intervention group
Modified Caregiver Strain










Demographic data will be collected from all participant groups. All clients will be asked to provide their age, gender, education, and diabetes history (duration,
family history). Clients and family caregivers will also be asked to provide household income, marital status, and comorbid health conditions. Caregivers will be
asked to provide their employment status and ethnic back ground. Interventionists will be asked about the number of years working in their field and the
number of years in their current role
aThree groups: CT client, CG caregiver, INT interventionists (e.g., RN, RD, PC)
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effectiveness. The primary outcome is the change in
Physical Component Summary (PCS-12) score from the
short form-12v2 health survey (SF-12) [58]. The SF-12 is
a generic quality-of-life instrument that is well-validated
and able to distinguish between groups of clients with
known clinical differences in a variety of populations
[58]. The pilot study supported the selection of the PCS-
12 score as the primary outcome by demonstrating that
the PCS-12 was responsive over the 6-month interven-
tion period and grounded in questions that were easily
interpreted by the older adult clients [43]. The PCS-12
is also a common primary outcome in studies evaluating
programs similar to ours [59] and focuses on an out-
come (physical functional ability) that is important to
clients [60]. Secondary outcomes include the change in
the following variables from baseline (T1) to 6 months
(T2): Mental Component Summary (MCS) score from
SF-12 [61]; Center for Epidemiological Studies Depres-
sion Scale (CES-D-10) [62–65]; Generalized Anxiety
Disorder 7-item scale (GAD-7) [66–70]; Summary of
Diabetes Self Care Activities (SDSCA) [71, 72]; and the
Modified Caregiver Strain Index (CSI) [73].
To better understand the mechanisms underlying the
changes in primary and secondary outcomes, changes
from baseline (T1) to 6 months (T2) in the following
measures will be assessed: (1) Self-Efficacy for Managing
Chronic Disease 6-item scale [52, 74–81]; items in the
scale are common across many chronic diseases, includ-
ing symptom control, role function, emotional function-
ing and communicating with physicians, and (2) Team
Climate Inventory (TCI) [82–84] (19-item); that includes
participative safety (trust in group members), support
for innovation (openness to new ideas), vision (shared
goals and valued outcomes), and task orientation (shared
concern for excellence) is evaluated.
Analyses
Analysis of participants
The data collected will be screened for accuracy, missing
data, outliers, and statistical assumptions. SAS Version
9.3 will be used for all statistical analyses. All statistical
tests will be performed using two-sided tests at the 0.05
significance level. For all models, the results will be
expressed as effects, standard errors, 95% confidence in-
tervals, and associated p values. The evaluation will be
conducted in accordance with the intention-to-treat
principle; therefore, imputation (using multiple imput-
ation) will be used to address missing data and compare
these results with the complete case analysis. If there are
discrepancies between the multiple imputation and
complete case results, we will conduct a sensitivity ana-
lysis using different multiple imputation methods (ap-
propriate for the pattern of missingness) to see how
robust the analysis is for the chosen method(s) of
handling missing data [85]. This procedure will result in
multiple data sets and models being run on each data
set. Appropriate methods will be used to combine the
results to generate pooled parameter estimates, standard
errors, and confidence limits.
An analysis of baseline (T1) data will be performed to
compare the demographic and clinical characteristics of
the intervention and control groups. This analysis will
confirm whether the two groups are equal on these vari-
ables. Means and standard deviations will be generated
for continuous variables, and frequencies and propor-
tions for categorical variables. The appropriate signifi-
cance test (e.g., t test for continuous measures, chi-
square for categorical) will be applied to identify any sig-
nificant differences between the groups. Significant dif-
ferences will be adjusted for in the outcomes analyses.
For the analyses relating to clients, t tests will be used
to compare the changes in primary and secondary out-
comes from baseline (T1) and 6 months (T2) in the two
groups. Primary and secondary measures will also be an-
alyzed using repeated measures ANCOVA (two time pe-
riods) to understand the factors shaping these outcomes.
Site will be included as a predictor, consistent with our
randomization strategy which stratified by site. Other
potential covariates include age, gender, self-efficacy,
duration of diabetes, and level of comorbidity. Covariates
will be identified and selected for inclusion in the models
based on bivariate analyses to confirm their relationship
with the outcome and the absence of a significant rela-
tionship with other covariates. We will conduct a cross-
jurisdictional comparison across Ontario and Alberta,
given the differences in community-based structures.
We will also examine the relationship between the
dose of the intervention and the primary outcome vari-
able (6-month PCS-12 score) in order to better under-
stand the mechanisms underlying this outcome and to
tease out quantity versus quality effects. Regression will
be used and dose will be measured by the number of
home visits and number of group sessions attended (ex-
plored as individual components and as a combined
measure).
The effectiveness of an intervention is often dependent
on the characteristics of the population; thus, this study
will include a subgroup analysis to identify what clients
benefit most from which approach to treatment [86]. A
range of characteristics thought to influence self-
management behavior will be evaluated, including: age,
gender, duration of diabetes, depressive symptoms, num-
ber of comorbidities, self-efficacy and caregiver support.
Regression using two-way interactions between the study
group (intervention versus control) and each characteris-
tic will be conducted to examine subgroup effects [87,
88]. The models will use the PCS-12 score for the
dependent variable and independent variables will
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include group assignment, client characteristic (e.g., at
least three versus less than three comorbidities), and the
interaction term.
Regarding the family caregivers, data on their
demographic characteristics and the three outcomes
(HRQoL, depressive symptoms, and strain) will be
collected at baseline and again at 6 months. Descrip-
tive statistics will be generated to summarize the
characteristics and outcomes for the family caregivers
in each group, with t tests and chi-square tests being
used to evaluate group differences in continuous and
categorical variables, respectively.
Statistical procedures for interventionist outcomes are
limited by the small number of individuals involved;
therefore, descriptive analysis will be mainly used to re-
port the results. We anticipate collecting 21 TCI assess-
ments (baseline and 6 months), one for each of three
members of the program team (RN, RD, PC) at each of
the sites. We will attempt to explore potential site differ-
ences and relationships with key variables (e.g., dose of
the intervention, primary and secondary outcomes of
T2DM clients).
Analysis of implementation
Outcomes Table 3 provides the implementation out-
comes and related measures for evaluating the imple-
mentation of the program. Implementation outcomes
include acceptability, appropriateness, adoption, feasibil-
ity, fidelity, reach (coverage), maintenance (sustainabil-
ity), and cost. Acceptability will be assessed using the
enrollment, attrition, and engagement rates (percentage
of study participants receiving at least one home visit
and attending at least one group session), and dose. Tar-
gets have been set for each of these measures based on
the medical literature and/or our pilot study results [43],
and observed values from the RCT will be compared to
the targets. The following targets have been set for the
RCT: enrollment rate of >50%, attrition rate of <20%, en-
gagement rate for home visits >90% and group sessions
>75%, and a median dose of three or more in-home
visits and attendance at group sessions.
Appropriateness and feasibility will be evaluated based
on the results of the monthly outreach meetings and
focus group sessions with interventionists. These
Table 3 Implementation outcomes – Measures and method of analysis
Implementation outcomes
Outcome Outcome measure(s) Methods of analysis
Acceptability: a willingness to receive the offered
intervention
- Enrollment rate (%)
- Attrition/retention rate (%)
- Engagement rate (% at least 1 home visit
and 1 group session)
- Dose of the intervention (number of
visits and/or group sessions attended)
- Compare observed rates to targets set for study
- Characteristics of consenters versus nonconsenters
- Descriptive statistics for total dose, number of
visits, number of group sessions
Appropriateness: from the perspective of
interventionists
- Perceived benefit to participants
- Convenience of implementation
Qualitative descriptive analysis of focus group and
outreach meetings
Adoption: the intervention is appealing to providers
and realistic to implement in practice
- Enrollment rate (%)
- Attrition/retention rate (%)
- Engagement rate (% at least 1 home visit
and 1 group session)
- Dose of the intervention (number of
visits and/or group sessions attended)
- Compare observed rates to targets set for study
- Characteristics of consenters versus
nonconsenters
- Descriptive statistics for total dose, number of
visits, number of group sessions
Feasibility: the capability to carry out intervention
activities
- Training of the interventionists
- Delivery of the program
- Perceptions of barriers and facilitators
- Evaluation of training materials, log sheets
- Qualitative descriptive method to analyze focus
group content
Fidelity: adherence to intervention components Refer to Fidelity Checklist (Additional file 3) - Review records of attendance at training session
and monthly meetings with researchers
- Review home visit records and log sheets to
assess delivery of the program as planned
Reach: degree to which the target population is
eligible to receive the intervention (coverage)
- Proportion of clients eligible
- Reasons for exclusion
- Characteristics of eligible clients
- Descriptive statistics
Maintenance: the extent to which the intervention
can be sustained
- Engagement rate (%)
- Attrition /retention (%)
- Reported reasons for attrition
- Prospects for the program’s uptake in
practice setting
- Descriptive statistics
- Qualitative descriptive method to analyze focus
group content
Cost: from a societal perspective - Health and Social Services Utilization
Inventory (HSSUI) [90]
- Comparison of baseline (T1) and 6-month (T2)
median costs using Mann-Whitney U test
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meetings and focus group sessions will provide information
on the perceived impact, and barriers and facilitators to im-
plementation of the program. Questions asked during the
focus group session will be guided by the CFIR [47] frame-
work which facilitates the systematic exploration of the ap-
propriateness and feasibility of the program in terms of
barriers and facilitators. CFIR focuses on examining the fol-
lowing key domains: intervention characteristics (e.g., com-
plexity of intervention, perception of benefits and relative
advantage compared to usual practice), outer setting (e.g.,
credibility of intervention by provider and senior administra-
tive agents), inner setting (e.g., team characteristics and en-
gagement, level of coordination and collaboration,
involvement of clients and caregivers, compatibility with
existing systems and resources), and individuals (e.g., enthu-
siasm and support for intervention, consistent tracking of ac-
tivities, reporting and resolving challenges, robust referrals).
Costing will assume a societal perspective [89], which im-
plies collecting all costs, regardless of who bears them. The
wider the perspective taken, the more applicable the study
is to social-policy decisions. The costs of use of all types of
health services from baseline to 6 months in T2DM clients
and their family caregivers will be determined using the
Health and Social Services Utilization Inventory (HSSUI)
[90]. The HSSUI consists of questions about the respon-
dent’s use of the following direct health care services: (1)
primary care, (2) emergency department and specialists, (3)
hospital days, (4) other health and community support ser-
vices, and (5) prescription medications. Services specific to
the program will be captured such as interventionist train-
ing, delivery of services in group sessions and in-home
visits, and attendance at case conferences and outreach
visits. Inquiries are restricted to the reliable duration
of recall: 6 months for remembering a hospitalization
and a visit to the physician, and 2 days for use of a
medication. The HSSUI builds on the work of
Browne et al. [91, 92] whose work was tested and
assessed for reliability and validity and was acknowl-
edged as one of the few published measures of ambu-
latory utilization that is empirically validated [93].
The 6-month cost data will be derived from “quan-
tity” data for the services identified in the HSSUI and
current “price” data for each service [90]. Services in-
clude: physician costs, home care services, outpatient
costs, X-rays, other health care providers, emergency
services, medication costs, tests, emergency room and
hospitalization, and caregiver support services [90].
The product of the number of units of service (quan-
tity) and unit cost (price) is total cost.
Implementation analyses
Table 3 also provides the types of analyses that will be
undertaken in the implementation evaluation. Both
quantitative and qualitative methods will be employed in
the evaluation, depending on the outcome being exam-
ined. Acceptability will be assessed by comparing ob-
served rates (e.g., enrollment, eligibility, engagement,
and dose) with preset targets. Many of these rates will
also be used in evaluating maintenance. Reach will be
assessed by reviewing baseline characteristics of the total
sample and comparing these to the broader population
of older adults with T2DM and MCC. A review of the
records on eligible clients will also be conducted, to
compare those that enroll in the study to those that do
not enroll, withdraw or are lost. These records will cap-
ture demographic characteristics (e.g., age, gender, co-
morbidity, and site) as well as the reasons clients
declined to participate, withdrew, or were lost. These
analyses will enable us to assess the representativeness
of the intervention group compared to those that were
eligible but declined to participate, withdrew, or were
lost. We will also examine the reasons for refusal and
evaluate whether declines can be attributed to the nature
of the program being offered.
Qualitative descriptive methods will be used to assess
the content of focus groups, outreach meeting records,
and other documents (e.g., log sheets documenting deliv-
ery of program components and principles used). Data
from the focus groups will be digitally recorded and tran-
scribed by an experienced transcriptionist and checked for
accuracy by a RA. The data will be managed using N-Vivo
10 software. Content analysis will be used to analyze the
transcripts. Two research investigators will independently
review all transcripts and inductively generate a list of
codes describing the content. The codes will then be
grouped into themes (a higher conceptual level) and sub-
themes. Difference of opinion between the two investiga-
tors will be discussed until agreement is reached.
The cost analyses will involve comparing the cost of
use of specific health and social services between the
intervention and control groups. Because cost data are
often right skewed, we anticipate using nonparametric
tests (e.g., Mann-Whitney U test) to evaluate differences
in median costs between the two groups. We will also
estimate the costs of the program, and total costs of
health care and social service in the two groups.
Discussion
This paper describes the design of a multisite, two-arm,
pragmatic, mixed-methods RCT of the effectiveness of
the ACHRU-CPP aimed at improving self-management
in older adults with T2DM and MCC and providing sup-
port to caregivers. This research makes several import-
ant contributions to the existing knowledge base. First, it
investigates the effectiveness of a self-management inter-
vention in a complex population. This population is par-
ticularly at risk of adverse outcomes, yet they are often
excluded from RCTs. As a result, their needs are poorly
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understood and evidence of the effectiveness of inter-
ventions aimed at behavioral change in this vulnerable
group is lacking. The exclusion of this group is import-
ant; about 60% of older adults with T2DM have at least
one comorbid condition and 40% have three or more
[8–10]. Second, the study includes a subgroup analysis
to determine which study clients benefit most from the
program. Few intervention studies conduct this type of
analysis, yet it is critical for informing the implementa-
tion of the program in other settings and to target scarce
resources to those most likely to benefit [86]. Third, the
study includes a cost analysis, which provides policy-
makers with critical information on the resource impli-
cations of the program to facilitate decision-making.
There are several strengths of the design of this study.
First, the intervention being evaluated targets behavioral
change, consistent with the epidemiological roots of
T2DM and supported by behavioral theory and empir-
ical results demonstrating the effectiveness, sustainability
and scalability of self-management interventions for
T2DM. Second, the study combines effectiveness and
implementation research, which is consistent with a
comprehensive approach to evaluation and offers the po-
tential to reduce the research-to-practice gap [42]. With
equal weighting assigned to both implementation and ef-
fectiveness, our study best fits the type-2 hybrid
effectiveness-implementation study design using the typ-
ology proposed by Curran et al. [42]. These researchers
argue that hybrid designs offer the potential to accelerate
the translation of research into routine practice, com-
pared to the more dominant approach of proceeding in
step-wise fashion (beginning with clinical efficacy, then
clinical effectiveness and finally implementation re-
search). Third, our study is designed to be rich in infor-
mation, providing a considerable amount of data
covering a range of outcomes (e.g., self-care, mental
health, self-efficacy, strain, collaboration) for multiple
stakeholders (e.g., clients, family caregivers, health care
providers). Fourth, we have chosen objective measures
for the outcomes examined, using well-established and
validated instruments. Finally, our study involves mul-
tiple sites and jurisdictions, which will enhance the
generalizability of the study’s findings.
There are some challenges that should also be ac-
knowledged. The study is examining the immediate 6-
month effects of the program, which represents the early
stages of implementation. While this timeframe was suf-
ficient to demonstrate the feasibility and potential effect-
iveness in the pilot study [43], it limits our ability to
comment on the long-term sustainability of the pro-
gram. We will not be able to forecast long-term behav-
ioral change in clients, nor will we be able to comment
on the program’s sustainability within the partner organi-
zations after the study concludes. During the interviews and
focus groups, we will ask interventionists about their in-
tentions to gain insight into the potential for sustain-
ability. Notably, the community partners who
participated in the pilot demonstrated “buy-in” and a
commitment to ongoing planning, implementation,
and evaluation of the program [43]. Adoption and im-
plementation has the potential to be high given that
the program involves the combination of diabetes ex-
pertise and increased accessibility because it is
community-based.
Self-management interventions are also recognized to be
challenging to implement when they are delivered in di-
verse community-based settings and feature a plan of care
that is individualized, sustainable, and targeted to a com-
plex population. The program is reliant on having resources
available within the community, and smaller or rural re-
gions might not have the sufficient infrastructure to offer
the program (or all aspects of it). It can also be difficult to
reach community-dwelling older adults with T2DM and
MCC. Recruiting targets typically set for younger demo-
graphics may not be realistic for this population [94]. Re-
tention may also be difficult; researchers have reported high
attrition rates in older populations [95, 96]. In an effort to
address these challenges, the study team will strengthen
training and communication with RAs. By using these
mechanisms, recruitment can be improved because inter-
viewers will be trained to build rapport and trust, while they
also rely on clear guidelines for participant contact, flexible
interview schedules that accommodate client preferences
and information that appropriately orients participants to
research including its procedures, risks, and benefits. Im-
portantly, participants will be given adequate time to decide
whether to participate. Similarly, retention will be enhanced
because interventionists will be guided to maintain regular
and personalized contact with participants for the duration
of the study. The research team will also facilitate reten-
tion by mailing reminder letters at 2 months and having
the RA make a reminder phone call at 4 months. The re-
searchers will also meet regularly with the interventionists
to proactively address any issues related to the delivery of
the program.
Finally, we have designed the program to be delivered
in two different jurisdictions and multiple sites. The
strength of this approach is that it will increase the
generalizability of the results, potentially improve the
uptake of results in new communities, and speed the
translation of research into practice. However, involving
multiple sites also introduces certain challenges. As this
is a pragmatic trial, we both expect and encourage inter-
ventionists to make adaptations to address their local
context and client needs. The risk is that these adapta-
tions may lead to variability in the program’s delivery,
particularly in component features and dose. Close moni-
toring will help the investigators to evaluate fidelity, or the
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consistency with which the components were applied, as
well as the dose of the intervention actually delivered [97].
We will examine the impact of this variation on outcomes,
similar to a dose-response analysis and address this in our
findings [97, 98]. We will track any adaptations that are
made to the program during its implementation. This infor-
mation will be used to guide future refinements and pre-
pare for a future study to test the program on a larger scale.
Ultimately, the study results will inform policy con-
cerning community-based interventions to enhance self-
management of T2DM. The study includes outcomes
for a range of stakeholders (clients, family caregivers,
health care providers) and includes a cost analysis. It will
inform both clients and health care providers and im-
prove our understanding of the effectiveness of group-
based interventions in changing self-management behav-
iors in a complex and underserved population (older
adults with T2DM and MCC). By including the evalu-
ation of both effectiveness and implementation in one
study design, we hope to enhance the relevance and sus-
tainability of the study results to clinicians and policy-
makers, and reduce the research-practice gap.
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